Alterity Therapeutics Ltd

(PRNAF)

By |

Profile

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.

Contact Information

Website: www.alteritytherapeutics.com
Email: info@pranabio.com
Main Phone: +61 393494906
Address: 460 Bourke Street
Address 2: Level 3
State: VIC
City / Town: Melbourne
Country: AUS
Postal Code: 3000

Issuer Information

Exchange: OTO
CEO: Geoffrey Paul Kempler
Employees: 14

Equities News

Profile

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.

Contact Information

Website: www.alteritytherapeutics.com
Email: info@pranabio.com
Main Phone: +61 393494906
Address: 460 Bourke Street
Address 2: Level 3
State: VIC
City / Town: Melbourne
Country: AUS
Postal Code: 3000

Issuer Information

Exchange: OTO
CEO: Geoffrey Paul Kempler
Employees: 14

Equities News

$ 0.0053 $ 0. (0.00%)
Last Price 0.0053 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.0053
Last Trade Volume 0 52 Wk Hi 0.07 52 Wk Low 0.01
Market Cap 4.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 1,037,358,032.00 EPS (TTM) -0.01 PE Ratio N/A Exchange OTCPK